Résumé :
|
[BDSP. Notice produite par INIST P91ZkR0x. Diffusion soumise à autorisation]. Elevated insulin levels may explain part of the increased risk of endometrial cancer observed in obese postmenopausal women. Circulating sex hormones and fasting C-peptide levels were measured in sera obtained from 165 postmenopausal endometrial cancer cases accrued between June 1,1987, and May 15,1990, from hospitals in Chicago, Illinois ; Hershey, Pennsylvania ; Irvine and Long Beach, California ; Minneapolis, Minnesota ; and Winston-Salem, North Carolina, and 180 community and hysterectomy controls. Women with a personal history of diabetes were excluded. Among controls, C-peptide was positively correlated with body mass index (BMI) ( (r=0.44), waist-to-thigh circumference ratio ( (r=0.24), estrone ( (r=0.18), and estradiol ( (r=0.28) (albumin-bound (r=0.45), and free (r=0.37)) and negatively correlated with sex hormone-binding globulin (r=-0.48). In age-adjusted analyses, the odds ratios and 95% confidence intervals for tertiles of C-peptide and endometrial cancer were, from lowest to highest : 1.0 (reference), 0.78 (95% confidence interval (Cl) 0.43-1.4), and 2.2 (95% CI 1.3-3.7). Further adjustment for BMI substantially attenuated the odds ratios for the highest tertile of C-peptide (odds ratio=1.2,95% Cl 0.63-2.1), and adjustment for body mass index and other risk factors for endometrial cancer eliminated the association (odds ratio=1.0,95% Cl 0.55-2.0). (...)
|